Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;62(6):823-828.
doi: 10.2967/jnumed.120.254623. Epub 2020 Oct 30.

Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network

Affiliations

Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network

Dejan Kostyszyn et al. J Nucl Med. .

Abstract

Accurate delineation of the intraprostatic gross tumor volume (GTV) is a prerequisite for treatment approaches in patients with primary prostate cancer (PCa). Prostate-specific membrane antigen PET (PSMA PET) may outperform MRI in GTV detection. However, visual GTV delineation underlies interobserver heterogeneity and is time consuming. The aim of this study was to develop a convolutional neural network (CNN) for automated segmentation of intraprostatic tumor (GTV-CNN) in PSMA PET. Methods: The CNN (3D U-Net) was trained on the 68Ga-PSMA PET images of 152 patients from 2 different institutions, and the training labels were generated manually using a validated technique. The CNN was tested on 2 independent internal (cohort 1: 68Ga-PSMA PET, n = 18 and cohort 2: 18F-PSMA PET, n = 19) and 1 external (cohort 3: 68Ga-PSMA PET, n = 20) test datasets. Accordance between manual contours and GTV-CNN was assessed with the Dice-Sørensen coefficient (DSC). Sensitivity and specificity were calculated for the 2 internal test datasets (cohort 1: n = 18, cohort 2: n = 11) using whole-mount histology. Results: The median DSCs for cohorts 1-3 were 0.84 (range: 0.32-0.95), 0.81 (range: 0.28-0.93), and 0.83 (range: 0.32-0.93), respectively. Sensitivities and specificities for the GTV-CNN were comparable with manual expert contours: 0.98 and 0.76 (cohort 1) and 1 and 0.57 (cohort 2), respectively. Computation time was around 6 s for a standard dataset. Conclusion: The application of a CNN for automated contouring of intraprostatic GTV in 68Ga-PSMA and 18F-PSMA PET images resulted in a high concordance with expert contours and in high sensitivities and specificities in comparison with histology as a reference. This robust, accurate and fast technique may be implemented for treatment concepts in primary prostate cancer. The trained model and the study's source code are available in an open source repository.

Keywords: PSMA-PET; convolutional neuronal networks; histopathology; prostate cancer; segmentation.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Visualization of the training and evaluation curves. Shown are training and evaluation results as dice loss and DSC (A) and HD and ASSD (B).
FIGURE 2.
FIGURE 2.
Histology reference projected on 68Ga-PSMA-11 (upper row) and 18F-PSMA-1007 (lower row). (A and C) Hematoxylin and eosin whole-mount prostate slide with marked PCa lesion. (B and D) Axial PET image (image windowing: SUVmin-max = 0–5). Blue contour = prostate; green contour = histology reference; yellow contour = GTV-Exp; yellow contour = GTV-CNN.
FIGURE 3.
FIGURE 3.
Specificity and sensitivity of GTV-CNN, GTV-Exp, and GTV-30% based on comparison with histology reference. (Upper row) Cohort 1 (68Ga-PSMA-11 PET). (Lower row) Cohort 2 (18F-PSMA-1007 PET). Box plots are presented. Pairwise comparison was performed with Wilcoxon signed-rank test. n.s. = not significant. *P = 0.05–0.01.

References

    1. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767–1777. - PMC - PubMed
    1. Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol. 2016;13:641–653. - PubMed
    1. Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208–1216. - PubMed
    1. Bettermann AS, Zamboglou C, Kiefer S, et al. [Ga-68-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard: implications for focal radiotherapy planning in primary prostate cancer. Radiother Oncol. 2019;141:214–219. - PubMed
    1. Eiber M, Weirich G, Holzapfel K, et al. Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70:829–836. - PubMed

Publication types